Stay updated on Clinical Trial: Osi+Sav in EGFRm+/MET+ NSCLC Post-Osi

Sign up to get notified when there's something new on the Clinical Trial: Osi+Sav in EGFRm+/MET+ NSCLC Post-Osi page.
Latest website image capture
Clouds background image

Latest updates to the Clinical Trial: Osi+Sav in EGFRm+/MET+ NSCLC Post-Osi page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The updates add posted results and expand efficacy/safety endpoints (ORR, DoR, PFS, OS) with detailed time frames; they also remove multiple protocol-based biospecimen collection and exploratory analyses.
    Difference
    4%
    Check dated 2026-02-13T11:58:01.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Added Revision: v3.4.1 and removed Revision: v3.4.0.
    Difference
    0.0%
    Check dated 2026-02-05T15:08:14.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    Footer now displays Revision: v3.3.4 and the previous Revision: v3.3.3 has been removed.
    Difference
    0.0%
    Check dated 2026-01-15T03:08:01.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    Added and updated the Locations sections to include California, District of Columbia, Maryland, Massachusetts, Minnesota, New York, Pennsylvania, Washington, and Alberta/Ontario; removed the prior state-location entries and the HHS Vulnerability Disclosure link.
    Difference
    0.6%
    Check dated 2025-12-24T14:36:17.000Z thumbnail image
  6. Check
    84 days ago
    Change Detected
    Summary
    Publications section added: Savolitinib Plus Osimertinib in Epidermal Growth Factor-Mutated, MET-Amplified Advanced Non-Small Cell Lung Cancer: A Randomized Phase II trial. This update does not alter the study design, eligibility criteria, endpoints, or enrollment.
    Difference
    0.0%
    Check dated 2025-12-02T17:57:23.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    The Publications section now states entries are automatically filled from PubMed and may not all pertain to the study, and the revision tag changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T14:50:04.000Z thumbnail image

Stay in the know with updates to Clinical Trial: Osi+Sav in EGFRm+/MET+ NSCLC Post-Osi

Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Osi+Sav in EGFRm+/MET+ NSCLC Post-Osi page.